New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
Grigoris T Gerotziafas,1,2 Isabelle Mahé,3 Ismail Elalamy1,21Service d'Hématologie Biologique, Hôpital Tenon, Hôpitaux Universitaires Est Parisien Assistance Publique Hôpitaux de Paris, Paris, France; 2ER2UPMC, Faculté de M&e...
Saved in:
Main Authors: | Gerotziafas GT (Author), Mahé I (Author), Elalamy I (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New anticoagulants for the prevention of venous thromboembolism
by: Cecilia Becattini, et al.
Published: (2010) -
Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015) -
Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015) -
New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism
by: Wumaier K, et al.
Published: (2022) -
The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment
by: К. V. Lobastov, et al.
Published: (2020)